Introduction
============

During auscultation of healthy individuals, vesicular breath sounds are small and low at the lung bases that are furthest from the large airways. Expiration occurs far from where the sounds are generated and this sound is audible, even during expiration, when a lesion is present in the airway ([@B1]). The changes in lung and/or airway conditions, may cause some subtle changes in the breath sounds auscultated at the lung bases. In our previous study, we used a computer-aided lung sound analysis (LSA) to investigate slight changes in breath sounds that are inaudible to the ear in patients with bronchial asthma. The patients were found to have higher exhalation-to-inhalation sound pressure ratios in the low frequency range between 100 and 195 Hz (E/I LF) ([@B2]). We have also reported that E/I LF can be easily obtained without any harm, which is useful for predicting a worsening of asthma ([@B3]).

Impulse oscillometry (IOS) is a method that is applied from the forced oscillation technique and which measures respiratory resistance and respiratory reactance using impulse signals containing low frequency (between 0 and 100 Hz) components. A correlation between the resistance of the respiratory system at 5 Hz (R5) measured by IOS and the forced expiratory volume in one second (FEV~1.0~) in bronchial asthma patients has been reported ([@B4]). IOS measurements, in addition to the spirometric determination of the maximal expiratory flow at 50% and 25% of FVC (%![](1349-7235-58-0047-i001.jpg)~50~ and %![](1349-7235-58-0047-i001.jpg)~25~), will not only enable the further differentiation of peripheral airway lesions but also serve as an index for monitoring the therapeutic course ([@B5]-[@B7]). This method has advantages in that it does not require forced exhalation and it can be applied quickly during quiet breathing, even for those of advanced age and/or an impaired lung function. A higher shift in respiratory system resistance or a lower shift in respiratory system reactance during exhalation in comparison to during inhalation, which is referred to as respiratory cycle dependence, was found in patients with severe bronchial asthma ([@B8],[@B9]).

We previously reported that E/I LF as well as reactance of the respiratory system at 5 Hz (X5) can be an indicator of central and peripheral airway obstruction in bronchial asthma patients ([@B10]); however, in that study we did not consider the respiratory cycle dependence of the IOS factors. In this study, we investigated the relationships between the E/I LF and respiratory cycle dependence of IOS in nonsmoking steroid-naive interictal patients with mild to moderate bronchial asthma and no rumbling or wheezing.

Materials and Methods
=====================

Subjects
--------

In the present study, 34 patients with mild to moderate bronchial asthma were assessed. The ages of the patients ranged from 20 to 65 years (average: 43.1 years); none of the patients were smoking at the time of the study (some had a past history of smoking). All patients fulfilled the Global Initiative for Asthma (GINA) criteria ([@B11]), and had a history of asthmatic symptoms, including recurrent cough, wheezing, or dyspnea, as well as positive airway hyper-responsiveness. The spirometry data, chest X ray and high-resolution CT (as needed in patients) findings showed no evidence of chronic obstructive pulmonary disease (COPD) in any patient. All patients retained a normal diffusion capacity. None of the patients had used inhaled or oral corticosteroids in the past. Anti-asthma drugs, including bronchodilators, were discontinued for at least 24 hours prior to this examination. Wheezing was not heard on auscultation in any patient.

The ethics committee of Fukuoka National Hospital approved the study protocol (protocol No.: 20-12), and all participants received verbal and written information about the study before they provided their informed consent.

Forced oscillation technique
----------------------------

The IOS MasterScreen device (Erich Jaeger, Wurzburg, Germany) consists of a loudspeaker as a pulse generator to send pressure impulses to the respiratory system. The system is calibrated through a single volume of air (3 L) at different flow rates and with a reference resistance device (0.2 kPa/L per second). The patients used nose clips and a disposable mouthpiece (Fit mouthpiece, Chest, Tokyo, Japan); patients supported their cheeks with their hands to decrease the shunt compliance. In this study, the mean respiratory resistance values (at inhalation, at exhalation and whole breath) were calculated over a measurement period of 30 seconds in a frequency range of 5-35 HZ. The impedance (Z), representing a complex airway resistance, which includes two components, the real resistance (R) and the imaginary reactance (X) were determined ([@B10],[@B12]).

Lung sound analysis (LSA)
-------------------------

Lung sounds were recorded using a hand-held microphone over the left lung base (where we could most clearly recognize the alveolar respiratory sound) for ≥30 seconds ([@B2],[@B13]). The recording system consisted of an electro-stethoscope containing a wide-range audio sensor that adhered to the inside of a diaphragm (Bio-Sound Sensor BSS-01; Kenzmedico, Saitama, Japan), a signal processing system, and a personal computer. The sensor had a band-pass filter range of 40-2,500 Hz and good sound-collecting ability in the 40-2,000 Hz range. The recorded sound was analyzed using a sound spectrometer (LSA-2008; Kenzmedico, Saitama, Japan). Single-breath cycle data with lower noise levels were selected visually and analyzed to determine the mean inhalation sound pressure level and the mean exhalation sound pressure in the 100-195-Hz frequency band. We defined the frequency range of 100-195 Hz as LF and determined the inspiration sound power, expiration sound power, and inspiration-to-expiration sound power ratio in the low-frequency range (E LF, I LF and E/I LF). The E/I LF data were converted from logarithmic values (dBm) ([@B2]). The sound recording was performed in a quiet room-but not a soundproof booth-in the outpatient department. The patients took a deep breath during the breath sound recording.

Measurement of the flow-volume curves
-------------------------------------

The lung function was measured using a spirometer (Chest Graph HI-701, Chest M.I., Tokyo, Japan). The results are expressed as the percentage of the predicted values based on the relevant reference standards ([@B14]).

Measurement of airway hyperresponsiveness to acetylcholine
----------------------------------------------------------

The challenge test was performed using the standard method. The subjects first inhaled isotonic saline for 2 minutes from a hand-held nebulizer (PARI BOY 038; PARI GmbH, Starnberg, Germany). They then inhaled Ach at concentrations that progressively doubled from 39 to 20,000 mcg/mL. The test was continued until the FEV1.0 decreased by ＞20%. Bronchial hyperresponsiveness was expressed as the provocative concentration of acetylcholine causing a 20% reduction in FEV~1~ (PC~20~). Subjects with a PC~20~ value of ＜8,000 mcg/mL were considered to have a positive bronchial hyperresponsiveness ([@B15]).

### Statistical analysis

The IOS parameters during inhalation and exhalation were compared using *t*-tests. The correlation between E/I LF and clinical factors or IOS parameters \[inhalation, exhalation, and the differences between exhalation and inhalation (Δ)\] were performed using Spearman\'s rank test. A stepwise method was used for the multivariate analysis of the correlation between E/I LF and clinical factors or IOS parameters. With regard to explanatory variables, sex and FEV~1.0,\ %predicted~ were selected as independent factors without confounders and the difference in the resistance of the respiratory system at 5 Hz between inhalation and exhalation (ΔR5), Δ\[R5- resistance of the respiratory system at 20 Hz (R20)\], and the difference in the resonant frequency of reactance between inhalation and exhalation (ΔFres) were repeatedly selected as IOS parameters. These statistical analyses were conducted using the JMP Pro software program (version 11, SAS Institute, Cary, USA) and the R software program (version 3.1.2).

Results
=======

Patient characteristics
-----------------------

The mean age of the patients was 43.1 years and the study population had a female predominance (male, n=4; female, n=30). None of the patients were current smokers; 13 had a history of smoking with a mean life-time tobacco use of 5.56 pack-years. The type of asthma was atopic in 18 patients and non-atopic in 16 patients. The study population had a mean logPC~20~ of 2.91, a mean FEV~1.0,\ %predicted.~ of 95.4%, and a mean ![](1349-7235-58-0047-i001.jpg)~50,\ %predicted~ of 72.5%. The patients had a mean E/I LF of 0.35 ([Table 1](#t001){ref-type="table"}).

###### 

Patient Characteristics.

                                                             Mean (95% CI)
  ------------------------------------------------------- -- -------------------
  Age (yr)                                                   43.1 (38.4-47.9)
  BMI                                                        22.6 (21.6-23.7)
  male/female                                                4 / 30
  Asthma duration (yr)                                       8.0 (4.2-11.8)
  Atopic/non-atopic                                          18 / 16
  Smoking non/ex/ current                                    21 / 13 / 0
  Smoking amount (pack-years)                                5.56 (1.80-9.32)
  Severity mild/moderate                                     14 / 20
  log IgE                                                    1.99 (1.73-2.25)
  PC~20~ (mcg/mL)                                            1,470 (940-2,000)
  logPC~20~                                                  2.91 (2.73-3.09)
  FEV~1.0~/FVC% (%)                                          78.4 (75.1-81.7)
  FEV~1.0,%predicted.~ (%)                                   95.4 (89.1-101.7)
  ![](1349-7235-58-0047-i001.jpg)~50,\ %predicted.~ (%)      72.5 (63.2-81.8)
  ![](1349-7235-58-0047-i001.jpg)~25,\ %predicted.~ (%)      53.8 (44.1-63.6)
  E/I LF                                                     0.35 (0.28-0.41)

Comparison of the inhalation and exhalation data from IOS
---------------------------------------------------------

The IOS R5, R20, and (R5-R20) values were significantly higher during exhalation than inhalation, whereas the reactance components \[reactance of the respiratory system at 5 Hz (X5), reactance area (AX) and Fres\] did not differ to a statistically significant extent between exhalation and inhalation ([Table 2](#t002){ref-type="table"}).

###### 

Comparison of the Impulse Oscillometry Parameters between Inhalation and Exhalation.

                                                           Inhalation        Exhalation         p value
  ----------------------------------------------------- -- -------------- -- --------------- -- ----------
  resistance of the respiratory system at 5 Hz (R5)        0.30 (0.09)       0.34 (0.10)        0.0003
  resistance of the respiratory system at 20 Hz (R20)      0.26 (0.08)       0.30 (0.08)        \<0.0001
  R5-R20                                                   0.03 (0.03)       0.05 (0.04)        0.049
  reactance of the respiratory system at 5 Hz              -0.11 (0.05)      -0.11 (-0.05)      0.476
  reactance area                                           0.34 (0.22)       0.38 (0.30)        0.297
  resonant frequency of reactance                          11.89 (2.84)      12.93 (4.11)       0.080

Data are presented by mean (standard deviation).

The correlations between E/I LF and the clinical factors and IOS parameters during inhalation, exhalation, and the difference between exhalation-inhalation (Δ)
---------------------------------------------------------------------------------------------------------------------------------------------------------------

With regard to the single correlations, the E/I LF was correlated with the disease period, FEV~1.0,\ %predicted~, ![](1349-7235-58-0047-i001.jpg)~50,\ %predicted~, logPC~20~, and log IgE. The E/I LF was significantly correlated with both the exhalation and inhalation data for R5 and R20. However, the E/I LF only showed a significant with the exhalation data (and not the inhalation data) for R5-R20, X5, AX, and Fres. The E/I LF was significantly correlated with ΔR5, Δ(R5-R20) and ΔFres ([Table 3a](#t003){ref-type="table"}).

In a stepwise multiple regression analysis to detect significant relationships, E/I LF, sex and FEV~1.0,\ %predicted~ (independent factors without an interrelationship) were included as clinical explanatory variables and each IOS parameter was added in a step-wise manner ([Table 3b](#t003){ref-type="table"}). E/I LF was higher in male patients (p＜0.05), patients with lower FEV~1.0,\ %predicted~ (p＜0.0001) (among clinical factors), and patients with a higher ΔR5 (p=0.035) or higher Δ(R5-R20) value (p=0.05) (among all analyzed IOS factors and differences in IOS factors between inhalation and exhalation).

###### 

Single Correlations (3a) and Multiple Regression Analysis (3b) of E/I LF with Clinical Factors and Impulse Oscillometry Parameters.

  3a                                                                            
  ------------------------------------------------------- ------- ------- -- -- --
  R5 In.                                                  0.36    0.035         
  R5 Ex.                                                  0.53    0.001         
  Δ R5                                                    0.48    0.004         
  R20 In.                                                 0.37    0.033         
  R20 Ex.                                                 0.4     0.018         
  Δ R20                                                   0.28    0.10          
  (R5-R20) In.                                            0.15    0.40          
  (R5-R20) Ex.                                            0.48    0.004         
  Δ (R5-R20)                                              0.36    0.035         
  X5 In.                                                  -0.28   0.11          
  X5 Ex.                                                  -0.49   0.004         
  ∆ X5                                                    -0.12   0.51          
  AX In.                                                  0.28    0.10          
  AX Ex.                                                  0.47    0.005         
  Δ AX                                                    0.22    0.21          
  Fres In.                                                0.31    0.08          
  Fres Ex.                                                0.47    0.005         
  Δ Fres                                                  0.35    0.04          
  age                                                     -0.24   0.17          
  Disease period                                          0.48    0.004         
  Smoking history                                         0.28    0.12          
  FEV~1.0,\ %predicted.~ (%)                              -0.53   0.001         
  ![](1349-7235-58-0047-i001.jpg)~50,\ %predicted.~ (%)   -0.36   0.036         
  ![](1349-7235-58-0047-i001.jpg)~25,\ %predicted.~ (%)   -0.31   0.078         
  logPC~20~                                               -0.43   0.001         
  log IgE                                                 0.36    0.036         

  ----------------------------------------------------------------
  3b                                                    
  ------------------- -------- -------- ------- ------- ----------
  Adjusted\                                             
  R\^2=0.528                                            

  SEX\[F\]            -0.112   -0.396   0.034   -3.29   0.003

  FEV~1~,%predicted   -0.006   -0.560   0.001   -4.67   \<0.0001

  ΔR5                 0.813    0.266    0.368   2.21    0.035

                                                        

  Adjusted\                                             
  R\^2=0.518                                            

  SEX\[F\]            -0.097   -0.344   0.036   -2.7    0.011

  FEV~1~,%predicted   -0.006   -0.556   0.001   -4.58   \<0.0001

  ΔR5-R20             1.432    0.260    0.702   2.04    0.050

                                                        

  Adjusted\                                             
  R\^2=0.495                                            

  SEX\[F\]            -0.112   -0.398   0.035   -3.19   0.003

  FEV~1~,%predicted   -0.006   -0.553   0.001   -4.45   0.0001

  ΔFres               0.011    0.203    0.007   1.61    0.117
  ----------------------------------------------------------------

E/I LF: expiration-to-inspiration sound power ratio in the low-frequency range, R5: resistance of the respiratory system at 5 Hz, In: inhalation, Ex: exhalation, Δ: the differences between exhalation and inhalation, R20: resistance of the respiratory system at 20 Hz, R5 - R20: difference between R5 and R20, X5: reactance of the respiratory system at 5 Hz, AX: reactance area, Fres: resonant frequency of reactance, FEV~1.0~: forced expiratory volume in one second, ![](1349-7235-58-0047-i001.jpg)~50~and ![](1349-7235-58-0047-i001.jpg)~25~: maximal expiratory flows at 50% and 25% of FVC, respectively, PC20: provocative concentration of acetylcholine causing a 20% decrease in the FEV~1.0~

Discussion
==========

In the present study, we found E/I LF to correlate with sex and FEV~1.0,\ %predicted~, and ΔR5 and Δ(R5-R20), which may suggest that the E/I LF mechanism is related to not only airway constriction, but also to respiratory cycle dependence.

In bronchial asthma patients, the sounds detected by LSA during exhalation are usually stronger than those detected during inhalation ([@B2]). The amplitude of a sound wave is an index of the airflow rate, which may have a greater impact on lung sounds ([@B16]-[@B18]). We calculated the exhalation-to-inhalation ratio and demonstrated that the E/I LF value can be used as an indicator of airway inflammation and obstruction in bronchial asthma ([@B2],[@B10]). We previously reported that E/I LF can be used similarly to X5 an indicator of the central and peripheral airway obstruction in bronchial asthma patients ([@B10]). X5 is reported as a parameter of peripheral capacitive reactance ([@B7]). A correlation between R5 (measured by IOS) and FEV~1.0~ in bronchial asthma patients has been reported ([@B4]) However, in these studies, the respiratory cycle dependence of IOS factors was not considered to explain the E/I LF mechanism. In this study, a multivariate analysis showed that E/I LF was correlated with ΔR5 or Δ(R5-R20), which may suggest the E/I LF is a respiratory cycle-dependent factor and that E/I LF may reflect the more peripheral airway situation.

Patients with bronchial asthma and COPD demonstrate respiratory cycle dependence on IOS; the inhalation-to-exhalation differences in the IOS reactance and resistance data of bronchial asthma and COPD patients differ from those of healthy individuals ([@B19]). The present study evaluated patients with bronchial asthma that was not complicated by COPD and found that among their IOS resistance components, their R5 values during exhalation were significantly higher than those during inhalation. However, female patients have lower E/I LF values; and Mori et al. demonstrated that patients with bronchial asthma had significant inhalation-to-exhalation differences in their R50, R20, R5-R20, Fres and AX values but not their X5 values ([@B20]). The E/I LF was significantly correlated with R5 and R20 during both exhalation and inhalation and with R5-R20 and X5, AX and Fres (reactance components), which are indicators of peripheral airway lesions during exhalation alone. Bronchial asthma is characterized by chronic airway inflammation with airway epithelial exfoliation. It is a respiratory disease involving airway obstruction that exhibits more pronounced expiratory airflow restriction due to airway smooth muscle constriction, airway edema, elevated airway secretion, airway wall remodeling, and other factors than those observed in normal exhalation. Moreover, E/I LF was independently correlated with ΔR5 and Δ(R5-R20), which may suggest the E/I LF reflects the respiratory cycle dependence of asthma. In this study, we hypothesize that the lower frequency of a smoking history in the male patients might have influenced the result. The independent negative relationship between FEV and E/I LF may suggest that the E/I LF is not only a respiratory cycle factor but that it also reflects the constriction of the airway.

This present study is associated with some limitations. First, the number of patients was small. We could not perform a multiple regression analysis with sufficient numbers of other factors, so we analyzed the relationships between E/I LF and some of the clinical factors or IOS parameters without confounding factors. Second, there was no unified view about whether the IOS parameters could indicate peripheral airway stenosis.

In conclusion, E/I LF was independently correlated with the changes of R5 and R5-R20 between exhalation and inhalation on IOS. E/I LF may express the respiratory cycle dependence of asthma as well as IOS.
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